4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-036254
Chairman and CEO bought 6,300 shares at an average $1.76 ($11,070)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-06-10 | Purchase | +1,500 | $1.78 | $2,670 | 10,664,893 | D |
| Niihara Yutaka Chairman and CEO | 2020-06-11 | Purchase | +4,800 | $1.75 | $8,400 | 10,669,693 | D |
| Open-market purchases · 6,300 sh · avg $1.76 · $11,070 | |||||||
Loading xslF345X03/doc4.xml…